Evaluation of low-prevalence Drug-Resistance Mutations by Next-Generation Sequencing.</p
The proportion of drug-resistant mutations selected by non-nucleoside reverse transcriptase inhibito...
<p>HIV drug resistance mutations detected by standard Sanger sequencing (SS) and by Deep sequencing ...
<p>Nucleotide variant information for re-sequencing projects conducted in current study.</p
Drug resistance mutations and reports obtained by Next-Generation Sequencing.</p
Mutations identified using next generation sequencing as stratified by the European society of medic...
<p>Drug resistance mutations identified in the patient samples sequenced using the Roche/454 GS Juni...
Comparison of mutations between Sanger Sequencing and Next-Generation Sequencing.</p
<p>Detection of drug-resistance mutations in treatment naive patients by PASS.</p
a-b & -c: Drug resistance interpretation reports with the resistance of drug mutations between Sange...
<p>Mutations identified through whole-genome sequencing of TDZ resistant mutants.</p
Prevalence of mutations identified in clusters by phylogenetic analysis of 251 sequences with drug r...
Boning up on mutations: assessing the significance of candidate disease-causing DNA sequence variati...
Boning up on mutations: assessing the significance of candidate disease-causing DNA sequence variati...
Boning up on mutations: assessing the significance of candidate disease-causing DNA sequence variati...
Mutations detected in the baseline drug resistance testing (bDRT); global results and results by pat...
The proportion of drug-resistant mutations selected by non-nucleoside reverse transcriptase inhibito...
<p>HIV drug resistance mutations detected by standard Sanger sequencing (SS) and by Deep sequencing ...
<p>Nucleotide variant information for re-sequencing projects conducted in current study.</p
Drug resistance mutations and reports obtained by Next-Generation Sequencing.</p
Mutations identified using next generation sequencing as stratified by the European society of medic...
<p>Drug resistance mutations identified in the patient samples sequenced using the Roche/454 GS Juni...
Comparison of mutations between Sanger Sequencing and Next-Generation Sequencing.</p
<p>Detection of drug-resistance mutations in treatment naive patients by PASS.</p
a-b & -c: Drug resistance interpretation reports with the resistance of drug mutations between Sange...
<p>Mutations identified through whole-genome sequencing of TDZ resistant mutants.</p
Prevalence of mutations identified in clusters by phylogenetic analysis of 251 sequences with drug r...
Boning up on mutations: assessing the significance of candidate disease-causing DNA sequence variati...
Boning up on mutations: assessing the significance of candidate disease-causing DNA sequence variati...
Boning up on mutations: assessing the significance of candidate disease-causing DNA sequence variati...
Mutations detected in the baseline drug resistance testing (bDRT); global results and results by pat...
The proportion of drug-resistant mutations selected by non-nucleoside reverse transcriptase inhibito...
<p>HIV drug resistance mutations detected by standard Sanger sequencing (SS) and by Deep sequencing ...
<p>Nucleotide variant information for re-sequencing projects conducted in current study.</p
DOI
Add to ORKG